Arena Pharma (NASDAQ: ARNA) reported Q2 EPS of ($1.24), $0.16 worse than the analyst estimate of ($1.08). Revenue for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE